FRETS‐VWF73, a first fluorogenic substrate for ADAMTS13 assay

By K. Kokame, Yuko Nobe, Y. Kokubo, A. Okayama, T. Miyata. British Journal of Haematology, 2005

596 citations recorded by the source corpus.

Subfields: Hematology, Immunology, Nephrology

View Paper: https://www.semanticscholar.org/paper/59e6fe41557b2ea5f278dca1afdbeb34e2def25a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Hematology

1. X. L. Zheng

In Immunology

1. S. Takeda
2. X. L. Zheng

In Nephrology

1. S. Takeda
2. X. L. Zheng

Citations in the corpus

• ADAMTS13 and von Willebrand Factor in Thrombotic Thrombocytopenic Purpura (2015, methodology): “Mancini I, Valsecchi C, Lotta LA, et al. FRETS-VWF73 rather than CBA assay reflects ADAMTS13 proteolytic activity in acquired thrombotic thrombocytopenic purpura patients.”
• ADAM and ADAMTS Family Proteins and Snake Venom Metalloproteinases: A Structural Overview (2016, background): “The F216E mutant, designed to impair the interactions between the M and D* domains, completely lost catalytic activity for the synthetic ADAMTS13 substrate FRET-VWF73 [132] although the secretion level was not greatly reduced [53].”